Results 181 to 190 of about 40,241 (253)

The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs. [PDF]

J Multidiscip Healthc
Gaujoux-Viala C, Tropé S, Buisson A, Lacombe F, Bocquet F, Languérand E, Cordurié L, Margulies G, Le Berre C, Vittecoq O.   +9 more
europepmc   +1 more source

Comparative outcomes of aflibercept biosimilars and reference aflibercept in nAMD: a systematic review and meta-analysis. [PDF]

BMJ Open Ophthalmol
Sawires K, Nithianandan H, Somani S.
europepmc   +1 more source

The biosimilars journey: current status and ongoing challenges [PDF]

, 2018
Igor Age Kos, Valderílio Feijó Azevedo, Daniel Egg Neto, Sérgio Cândido Kowalski   +3 more
openalex   +1 more source

Comparative Safety Analysis of Avastin and Bevacizumab Biosimilars Based on Food and Drug Administration Adverse Event Reporting System. [PDF]

Basic Clin Pharmacol Toxicol
Zhang X, Zhang Y, Tang X, Chen L.
europepmc   +1 more source

Knowledge, Attitudes, and Practices Regarding Biosimilars Among Pharmacists and Physicians in Saudi Arabia: A Scoping Review. [PDF]

Cureus
Alanizi A, Alotaibi R, Babalghaith R, Alzahrani A, Qubaiban R, Hattan A, Alnuhait M, Al Sharif A.   +7 more
europepmc   +1 more source

Barriers to Biosimilar Approval: Creating Clarity Through the Publication of Product-Class Specific Guidances [PDF]

, 2016
McEnrue, Martin
core  

Biochemical and Biophysical Divergences between Two Escherichia coli l-Asparaginase II Variants: Potential for Using EcA2-K12 as a Biosimilar

Talita Stelling de Araújo, Ariane Pereira Da Costa, Carolina Silva, Fernando de Sá Ribeiro, Rafael Alves de Andrade, Heitor A. Paula Neto, Renato S. Carvalho, Luís Maurício T. R. Lima, Marcius S. Almeida   +8 more
openalex   +1 more source

How Similar Is Biosimilar? A Comparison of Infliximab Therapeutics in Regard to Charge Variant Profile and Antigen Binding Affinity

, 2018
Beate Beyer, Nicole Walch, Alois Jungbauer, Nico Lingg   +3 more
openalex   +1 more source

Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study. [PDF]

BioDrugs
Car E, Barbier L, Schwarzenberger I, Huys I, Simoens S, Vulto AG.   +5 more
europepmc   +1 more source

Biosimilars: State of Clinical and Regulatory Science

, 2017
Ágnes Klein, Jian Wang, Brian G. Feagan, Mark Omoto   +3 more
openalex   +1 more source